Meta Platforms Inc. today debuted an image generation model that can write code and search the web. Muse Image is the second ...

Armored Likho BusySnake Stealer, a Python-based infostealer first disclosed by Kaspersky, is actively targeting government ...

The former majority owner of TikTok has quietly continued to court filmmakers, independent artists and executives who are ...

Katelyn is a reporter with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Abstract: Large language models (LLMs) are increasingly being used in various domains, including chip design. Recent works have demonstrated the effectiveness of LLMs in EDA tool script generation.

Discover the top 12 tools in 2026, from Cursor to Copilot, to speed up daily dev workflows and build apps faster!

EaseMate AI offers an advanced yet easy-to-use AI video creator that helps you turn text prompts, images, or short scripts into high-quality videos. It combines text-to-video, image-to-video, and AI ...

According to @pictoryai on X, Pictory’s AI script generator converts a simple prompt into structured, ready‑to‑edit video scripts within seconds, accelerating the workflow from concept to content ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...